blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3641833

EP3641833 - METHODS AND COMPOSITIONS FOR CONTROLLING CARDIAC FIBROSIS AND REMODELING [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  19.11.2020
Database last updated on 05.07.2024
FormerRequest for examination was made
Status updated on  27.03.2020
FormerThe international publication has been made
Status updated on  31.12.2018
Formerunknown
Status updated on  23.06.2018
Most recent event   Tooltip24.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Université de Lausanne
Rue de Bugnon 21
1011 Lausanne / CH
[2020/18]
Inventor(s)01 / OUNZAIN, Samir
Avenue de Beaumont 56
1010 Lausanne / CH
02 / PEDRAZZINI, Thierry
Chemin des Grisons 1
1052 Le Mont-sur-Lausanne / CH
 [2020/23]
Former [2020/18]01 / OUNZAIN, Samir
Chemin Isabelle-de-Montolieu 90
1010 Lausanne / CH
02 / PEDRAZZINI, Thierry
Chemin des Grisons 1
1052 Le Mont-sur-Lausanne / CH
Representative(s)KATZAROV S.A.
Geneva Business Center
12 Avenue des Morgines
1213 Petit-Lancy / CH
[N/P]
Former [2020/18]KATZAROV S.A.
European Patent Attorneys
12, Avenue des Morgines
1213 Petit-Lancy / CH
Application number, filing date18730384.719.06.2018
[2020/18]
WO2018EP66206
Priority number, dateEP2017017672519.06.2017         Original published format: EP 17176725
[2020/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018234283
Date:27.12.2018
Language:EN
[2018/52]
Type: A1 Application with search report 
No.:EP3641833
Date:29.04.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 27.12.2018 takes the place of the publication of the European patent application.
[2020/18]
Search report(s)International search report - published on:EP27.12.2018
ClassificationIPC:A61K48/00, C12N15/113, A61K31/7088, C12N15/63
[2020/18]
CPC:
C12N15/113 (EP,US); A61K31/7088 (EP,US); A61P9/00 (EP);
C12N9/22 (US); C12N2310/11 (EP,US); C12N2310/141 (US);
C12N2310/20 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/18]
Extension statesBA16.01.2020
ME16.01.2020
Validation statesKH16.01.2020
MA16.01.2020
MD16.01.2020
TN16.01.2020
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR KONTROLLE VON HERZFIBROSE UND REMODELLIERUNG[2020/18]
English:METHODS AND COMPOSITIONS FOR CONTROLLING CARDIAC FIBROSIS AND REMODELING[2020/18]
French:MÉTHODES ET COMPOSITIONS POUR RÉGULER LA FIBROSE ET LE REMODELAGE CARDIAQUE[2020/18]
Entry into regional phase16.01.2020National basic fee paid 
16.01.2020Designation fee(s) paid 
16.01.2020Examination fee paid 
Examination procedure16.01.2020Examination requested  [2020/18]
16.01.2020Date on which the examining division has become responsible
07.07.2020Amendment by applicant (claims and/or description)
18.11.2020Despatch of a communication from the examining division (Time limit: M04)
12.03.2021Reply to a communication from the examining division
22.02.2022Despatch of a communication from the examining division (Time limit: M06)
22.08.2022Reply to a communication from the examining division
26.06.2023Despatch of a communication from the examining division (Time limit: M06)
08.11.2023Reply to a communication from the examining division
Fees paidRenewal fee
16.01.2020Renewal fee patent year 03
25.06.2021Renewal fee patent year 04
29.06.2022Renewal fee patent year 05
20.06.2023Renewal fee patent year 06
24.06.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2015092020  (UNIVERSITÉ DE LAUSANNE [CH]);
 [X]WO2015162161  (HANNOVER MED HOCHSCHULE [DE]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.